New Key Statistics Module, Z-Score and F-Score
AMEX:IGC Key Ratios
| Market Cap $ M | 28.50 |
| Enterprise Value $ M | 27.38 |
| P/E(ttm) | -- |
| PE Ratio without NRI | -- |
| Forward PE Ratio | -- |
| Price/Book | 3.68 |
| Price/Sales | 21.65 |
| Price/Free Cash Flow | -- |
| Price/Owner Earnings | -- |
| Payout Ratio % | -- |
| Revenue (TTM) $ M | 1.00 |
| EPS (TTM) $ | -0.18 |
| Beneish M-Score | -5.06 |
| 10-y EBITDA Growth Rate % | -3.40 |
| 5-y EBITDA Growth Rate % | -5.70 |
| y-y EBITDA Growth Rate % | -- |
| EV-to-EBIT | -2.94 |
| EV-to-EBITDA | -3.15 |
| PEG | -- |
| Shares Outstanding M | 77.45 |
| Net Margin (%) | -1,062.47 |
| Operating Margin % | -788.17 |
| Pre-tax Margin (%) | -1,062.47 |
| Quick Ratio | 0.98 |
| Current Ratio | 1.52 |
| ROA % (ttm) | -107.19 |
| ROE % (ttm) | -137.43 |
| ROIC % (ttm) | -101.02 |
| Dividend Yield % | -- |
| Altman Z-Score | -13.90 |
IGC Number of Guru Trades
IGC Volume of Guru Trades
Gurus Latest Trades with AMEX:IGC
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
AMEX:IGC is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
IGC Pharma Inc Insider Transactions
No Available Data
News about AMEX:IGC
Total 0- 1
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers